Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells

The new era of nanotechnology, an alternative to change cancer treatment

(2017) Ancuta Jurj et al.   Drug Design Development and Therapy

Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?

(2017) Rita Mendes et al.   Genes

Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment

(2017) Keitaro Hayashi et al.   World Journal of Gastrointestinal Oncology

Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery

(2016) Y. Gilad et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells

(2016) Y. Gilad et al.   BIOPOLYMERS

Selected Standard Protocols for the Synthesis, Phase Transfer, and Characterization of Inorganic Colloidal Nanoparticles

(2016) Jonas Hühn et al.   CHEMISTRY OF MATERIALS

Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine

(2016) Iliyas Khan et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Antibody–drug conjugates for cancer therapy

(2016) Anish Thomas et al.   LANCET ONCOLOGY

Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity

(2016) Mehdi Shafiee Ardestani et al.   OncoTargets and Therapy

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Advances in phage display technology for drug discovery

(2015) Kobra Omidfar et al.   Expert Opinion on Drug Discovery

Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells

(2015) C Arimany-Nardi et al.   PHARMACOGENOMICS JOURNAL

Drug Carriers for the Delivery of Therapeutic Peptides

(2014) Alice W. Du et al.   BIOMACROMOLECULES

“Switch off/switch on” regulation of drug cytotoxicity by conjugation to a cell targeting peptide

(2014) Yossi Gilad et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Novel Hybrids of Natural Oridonin-Bearing Nitrogen Mustards as Potential Anticancer Drug Candidates

(2014) Shengtao Xu et al.   ACS Medicinal Chemistry Letters

Nucleic acid-directed self-assembly of multifunctional gold nanoparticle imaging agents

(2013) Ziyan Zhang et al.   Biomaterials Science

Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo

(2012) Keyang Huang et al.   ACS Nano

Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide

(2012) Gary Gellerman et al.   ANTI-CANCER DRUGS

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

(2012) Wolfgang U. Knauf et al.   BRITISH JOURNAL OF HAEMATOLOGY

Synthesis, characterization andin vitrostudies of pegylated melphalan conjugates

(2012) Ajazuddin et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Targeted drug delivery for cancer therapy: the other side of antibodies

(2012) Michael A Firer et al.   Journal of Hematology & Oncology

Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin

(2012) Joan Comenge et al.   PLoS One

Monolayer coated gold nanoparticles for delivery applications

(2011) Subinoy Rana et al.   ADVANCED DRUG DELIVERY REVIEWS

Drug delivery and nanoparticles: Applications and hazards

(2010) de Jong   International Journal of Nanomedicine

Control of the catalytic properties and directed assembly on surfaces of MADIX/RAFT polymer-coated gold nanoparticles by tuning polymeric shell charge

(2010) Mariana Beija et al.   JOURNAL OF MATERIALS CHEMISTRY

Gold nanoparticles in delivery applications☆

(2008) P GHOSH et al.   ADVANCED DRUG DELIVERY REVIEWS

Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents

(2008) L. M. Leoni et al.   CLINICAL CANCER RESEARCH

Bendamustine

(2008) Michael J. Keating et al.   NATURE REVIEWS DRUG DISCOVERY